Search hospitals > California > Santa Monica
Sarcoma Oncology Center
Claim this profileSanta Monica, California 90403
Global Leader in Sarcoma
Global Leader in Tumors
Conducts research for Solid Tumors
Conducts research for Soft Tissue Sarcoma
Conducts research for Cancer
121 reported clinical trials
10 medical researchers
Summary
Sarcoma Oncology Center is a medical facility located in Santa Monica, California. This center is recognized for care of Sarcoma, Tumors, Solid Tumors, Soft Tissue Sarcoma, Cancer and other specialties. Sarcoma Oncology Center is involved with conducting 121 clinical trials across 129 conditions. There are 10 research doctors associated with this hospital, such as Victoria Chua-Alcala, MD, Sant P Chawla, MD, Victoria Chua, MD, and Erlinda M Gordon, MD.Area of expertise
1Sarcoma
Global LeaderStage IV
Stage III
0
2Tumors
Global LeaderStage IV
Stage III
TP53 negative
Top PIs
Victoria Chua-Alcala, MDSarcoma Oncology Research Center6 years of reported clinical research
Expert in Sarcoma
Expert in Solid Tumors
44 reported clinical trials
63 drugs studied
Sant P Chawla, MDSarcoma Oncology Research Center1 year of reported clinical research
Expert in Sarcoma
Expert in Soft Tissue Sarcoma
40 reported clinical trials
55 drugs studied
Victoria Chua, MDSarcoma Oncology Center3 years of reported clinical research
Studies Sarcoma
Studies Cancer
8 reported clinical trials
13 drugs studied
Erlinda M Gordon, MDSarcoma Oncology Research Center1 year of reported clinical research
Studies Sarcoma
Studies Soft Tissue Sarcoma
5 reported clinical trials
6 drugs studied
Clinical Trials running at Sarcoma Oncology Center
Solid Tumors
Sarcoma
Tumors
Soft Tissue Sarcoma
Ovarian Cancer
Cancer
Chondrosarcoma
Breast Cancer
Glioblastoma
Colorectal Cancer
Lurbinectedin + Irinotecan
for Cancer
Prospective, open-label, dose-ranging, uncontrolled phase I/II study of Lurbinectedin in combination with irinotecan. The study will be divided into two stages: a Phase I dose escalation stage and a Phase II expansion stage.
Recruiting2 awards Phase 1 & 213 criteria
BBI-825
for Solid Tumors
BBI-825 is a potent, selective, oral, small molecule inhibitor of ribonucleotide reductase (RNR). This is a first-in-human, open-label, non-randomized, 3-part, Phase 1/2 study to determine the safety profile and identify the maximum tolerated dose and recommended Phase 2 dose of BBI-825 administered as a single agent and in combination with select targeted therapies.
Recruiting1 award Phase 1
ADCT-601 + Gemcitabine
for Cancer
The primary objective of this study is to identify the recommended phase 2 dose (RP2D) and/or the maximum tolerated dose (MTD), and characterize the safety and tolerability of ADCT-601 monotherapy and in combination with gemcitabine.
Recruiting1 award Phase 116 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sarcoma Oncology Center?
Sarcoma Oncology Center is a medical facility located in Santa Monica, California. This center is recognized for care of Sarcoma, Tumors, Solid Tumors, Soft Tissue Sarcoma, Cancer and other specialties. Sarcoma Oncology Center is involved with conducting 121 clinical trials across 129 conditions. There are 10 research doctors associated with this hospital, such as Victoria Chua-Alcala, MD, Sant P Chawla, MD, Victoria Chua, MD, and Erlinda M Gordon, MD.